1. Scrip
  2. >>Focus On Asia
  3. >>Japan

Japan Physician Groups' Controversial Push For Xocova Backfires

 
• By Lisa Takagi

A controversial letter from two Japanese doctors' associations seemingly pressing regulators to approve Shionogi’s oral COVID-19 drug prompts a backlash from other physicians. 

Several Japanese Doctors Openly Rejected the idea Of approving Xocova without proving efficacy
Several Japanese Doctors Openly Rejected the idea Of approving Xocova without proving efficacy • Source: Shutterstock

Japan has been encouraging domestic pharmaceutical firms to develop vaccines and therapeutic drugs to tackle COVID-19.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Japan

More from Focus On Asia